Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
ENDPOINTS
editor@endpointsnews.com
author articles
SOTIO, Biocytogen to jointly develop antibodies; Pliant's mid-stage liver disease data
11 months ago
News Briefing
Evofem inks women’s health deal; AusperBio brings in $37M
12 months ago
News Briefing
Faron details clinical plans for MDS drug; Cara to seek 'strategic' options
12 months ago
News Briefing
Ideaya aims to raise $263M; Immuneel extends Series A with $12M
Last year
News Briefing
Kymera's stock rises after derma investigation expands; Ligand buys Apeiron
Last year
News Briefing
Vanqua raises $45M; Aerovate to look for strategic alternatives
Last year
News Briefing
Innovent reworks deal with IASO; Granza raises $7M
Last year
News Briefing
'Optimizing R&D structure is also on the horizon, without exception,' new Sumitomo Pharma CEO says
Last year
Pharma
Nikkei Biotechnology
Yuhan, Ubix ink licensing deal; Xenpozyme's royalty deal
Last year
News Briefing
Tracon to seek ‘strategic’ options; Ovid to lay off 17 workers
Last year
News Briefing
Savara’s $100M offering; New biotech to test Eisai drug in Ph2
Last year
News Briefing
Recursion’s $200M offering; Sanofi invests $40M in Vigil Neuroscience
Last year
News Briefing
Taysha’s $75M offering; Augustine raises €17M
Last year
News Briefing
Zealand Pharma aims to raise $900M; Boehringer discontinues three Phase 2 trials
Last year
News Briefing
Biopharma leaders charting a path for the industry's LGBTQ+ community
Last year
People
Special
Corrected: Entrada raises $100M for Duchenne development; eFFECTOR winds down
Last year
News Briefing
Forbion's new €75M fund; Cara Therapeutics to cut workforce after trial failure
Last year
News Briefing
A new obesity biotech; UroGen aims to raise $107M
Last year
News Briefing
Argenx drops post-Covid syndrome program; Mirum picks a dose for bile duct disease drug
Last year
News Briefing
Takeda signs option deal for TKI inhibitor; Enveda's $55M raise
Last year
News Briefing
Alzheon raises $100M; Regeneron ends mid-stage trial
Last year
News Briefing
ADC startup raises €30M; Cyrus Biotechnology to spin out Levitate Bio
Last year
News Briefing
Shionogi inks deal for preclinical hearing loss therapies; Alvotech’s refinancing pact
Last year
News Briefing
ArriVent inks ADC deal with Alphamab; Annexon's $125M offering
Last year
News Briefing
First page
Previous page
7
8
9
10
11
12
13
Next page
Last page